Back to Search Start Over

Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019

Authors :
Cortesi, P
Fornari, C
Conti, S
Antonazzo, I
Ferrara, P
Ahmed, A
Andrei, C
Andrei, T
Artamonov, A
Banach, M
Baravelli, C
Barnighausen, T
Bhagavathula, A
Briko, N
Calina, D
Carreras, G
Chung, S
Dianatinasab, M
Dubljanin, E
Durojaiye, O
Ezeonwumelu, I
Fagbamigbe, A
Fischer, F
Gallus, S
Glushkova, E
Golinelli, D
Gorini, G
Hassan, S
Hay, S
Hostiuc, M
Ilic, I
Ilic, M
Jakovljevic, M
Jamshidi, E
Jozwiak, J
Kabir, Z
Kauppila, J
Khalilov, R
Khan, M
Khatab, K
Koyanagi, A
La Vecchia, C
Lazarus, J
Ledda, C
Levi, M
Lopukhov, P
Loureiro, J
Matthews, P
Mentis, A
Mestrovic, T
Moazen, B
Mohammed, S
Monasta, L
Mulita, F
Murray, C
Negoi, I
Oancea, B
Palladino, C
Patel, J
Petcu, I
Postma, M
Rawaf, D
Rawaf, S
Romero-Rodriguez, E
Santric-Milicevic, M
Skryabin, V
Skryabina, A
Tabares-Seisdedos, R
Tampa, M
Taveira, N
Thiyagarajan, A
Tovani-Palone, M
Westerman, R
Zastrozhin, M
Mazzaglia, G
Mantovani, L
Cortesi P. A.
Fornari C.
Conti S.
Antonazzo I. C.
Ferrara P.
Ahmed A.
Andrei C. L.
Andrei T.
Artamonov A. A.
Banach M.
Baravelli C. M.
Barnighausen T. W.
Bhagavathula A. S.
Briko N. I.
Calina D.
Carreras G.
Chung S. -C.
Dianatinasab M.
Dubljanin E.
Durojaiye O. C.
Ezeonwumelu I. J.
Fagbamigbe A. F.
Fischer F.
Gallus S.
Glushkova E. V.
Golinelli D.
Gorini G.
Hassan S.
Hay S. I.
Hostiuc M.
Ilic I. M.
Ilic M. D.
Jakovljevic M.
Jamshidi E.
Jozwiak J. J.
Kabir Z.
Kauppila J. H.
Khalilov R.
Khan M. A.
Khatab K.
Koyanagi A.
La Vecchia C.
Lazarus J. V.
Ledda C.
Levi M.
Lopukhov P. D.
Loureiro J. A.
Matthews P. C.
Mentis A. -F. A.
Mestrovic T.
Moazen B.
Mohammed S.
Monasta L.
Mulita F.
Murray C. J. L.
Negoi I.
Oancea B.
Palladino C.
Patel J.
Petcu I. -R.
Postma M. J.
Rawaf D. L.
Rawaf S.
Romero-Rodriguez E.
Santric-Milicevic M. M.
Skryabin V. Y.
Skryabina A. A.
Tabares-Seisdedos R.
Tampa M.
Taveira N.
Thiyagarajan A.
Tovani-Palone M. R.
Westerman R.
Zastrozhin M. S.
Mazzaglia G.
Mantovani L. G.
Cortesi, P
Fornari, C
Conti, S
Antonazzo, I
Ferrara, P
Ahmed, A
Andrei, C
Andrei, T
Artamonov, A
Banach, M
Baravelli, C
Barnighausen, T
Bhagavathula, A
Briko, N
Calina, D
Carreras, G
Chung, S
Dianatinasab, M
Dubljanin, E
Durojaiye, O
Ezeonwumelu, I
Fagbamigbe, A
Fischer, F
Gallus, S
Glushkova, E
Golinelli, D
Gorini, G
Hassan, S
Hay, S
Hostiuc, M
Ilic, I
Ilic, M
Jakovljevic, M
Jamshidi, E
Jozwiak, J
Kabir, Z
Kauppila, J
Khalilov, R
Khan, M
Khatab, K
Koyanagi, A
La Vecchia, C
Lazarus, J
Ledda, C
Levi, M
Lopukhov, P
Loureiro, J
Matthews, P
Mentis, A
Mestrovic, T
Moazen, B
Mohammed, S
Monasta, L
Mulita, F
Murray, C
Negoi, I
Oancea, B
Palladino, C
Patel, J
Petcu, I
Postma, M
Rawaf, D
Rawaf, S
Romero-Rodriguez, E
Santric-Milicevic, M
Skryabin, V
Skryabina, A
Tabares-Seisdedos, R
Tampa, M
Taveira, N
Thiyagarajan, A
Tovani-Palone, M
Westerman, R
Zastrozhin, M
Mazzaglia, G
Mantovani, L
Cortesi P. A.
Fornari C.
Conti S.
Antonazzo I. C.
Ferrara P.
Ahmed A.
Andrei C. L.
Andrei T.
Artamonov A. A.
Banach M.
Baravelli C. M.
Barnighausen T. W.
Bhagavathula A. S.
Briko N. I.
Calina D.
Carreras G.
Chung S. -C.
Dianatinasab M.
Dubljanin E.
Durojaiye O. C.
Ezeonwumelu I. J.
Fagbamigbe A. F.
Fischer F.
Gallus S.
Glushkova E. V.
Golinelli D.
Gorini G.
Hassan S.
Hay S. I.
Hostiuc M.
Ilic I. M.
Ilic M. D.
Jakovljevic M.
Jamshidi E.
Jozwiak J. J.
Kabir Z.
Kauppila J. H.
Khalilov R.
Khan M. A.
Khatab K.
Koyanagi A.
La Vecchia C.
Lazarus J. V.
Ledda C.
Levi M.
Lopukhov P. D.
Loureiro J. A.
Matthews P. C.
Mentis A. -F. A.
Mestrovic T.
Moazen B.
Mohammed S.
Monasta L.
Mulita F.
Murray C. J. L.
Negoi I.
Oancea B.
Palladino C.
Patel J.
Petcu I. -R.
Postma M. J.
Rawaf D. L.
Rawaf S.
Romero-Rodriguez E.
Santric-Milicevic M. M.
Skryabin V. Y.
Skryabina A. A.
Tabares-Seisdedos R.
Tampa M.
Taveira N.
Thiyagarajan A.
Tovani-Palone M. R.
Westerman R.
Zastrozhin M. S.
Mazzaglia G.
Mantovani L. G.
Publication Year :
2023

Abstract

Background: In 2016, the World Health Assembly adopted the resolution to eliminate viral hepatitis by 2030. This study aims to provide an overview of the burdens of hepatitis B virus (HBV) and hepatitis C virus (HCV) in Europe and their changes from 2010 to 2019 using estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. Methods: We used GBD 2019 estimates of the burden associated with HBV-related and HCV-related diseases: acute hepatitis, cirrhosis and other chronic liver diseases, and liver cancer. We report total numbers and age-standardised rates per 100 000 for mortality, prevalence, incidence, and disability-adjusted life-years (DALYs) from 2010 to 2019. For each HBV-related and HCV-related disease and each measure, we analysed temporal changes and percentage changes for the 2010–19 period. Findings: In 2019, across all age groups, there were an estimated 2·08 million (95% uncertainty interval [UI] 1·66 to 2·54) incident cases of acute hepatitis B and 0·49 million (0·42 to 0·57) of hepatitis C in Europe. There were an estimated 8·24 million (7·56 to 8·88) prevalent cases of HBV-related cirrhosis and 11·87 million (9·77 to 14·41) of HCV-related cirrhosis, with 24·92 thousand (19·86 to 31·03) deaths due to HBV-related cirrhosis and 36·89 thousand (29·94 to 45·56) deaths due to HCV-related cirrhosis. Deaths were estimated at 9·00 thousand (6·88 to 11·62) due to HBV-related liver cancer and 23·07 thousand (18·95 to 27·31) due to HCV-related liver cancer. Between 2010 and 2019, the age-standardised incidence rate of acute hepatitis B decreased (–22·14% [95% UI –35·44 to –5·98]) as did its age-standardised mortality rate (–33·27% [–43·03 to –25·49]); the age-standardised prevalence rate (–20·60% [–22·09 to –19·10]) and mortality rate (–33·19% [–37·82 to –28·13]) of HBV-related cirrhosis also decreased in this time period. The age-standardised incidence rate of acute hepatitis C decreased by 3·24% (1·17 to 5·02) and its age-standa

Details

Database :
OAIster
Notes :
ELETTRONICO, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1427431493
Document Type :
Electronic Resource